Avalon Investment & Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $11.4M | Buy |
+13,831
| New | +$11.4M | 0.31% | 99 |
|
|
2021
Q2 | – | Sell |
-775
| Closed | -$367K | – | 367 |
|
|
2021
Q1 | $367K | Sell |
775
-739
| -49% | -$350K | 0.01% | 303 |
|
|
2020
Q4 | $731K | Sell |
1,514
-902
| -37% | -$436K | 0.01% | 273 |
|
|
2020
Q3 | $1.35M | Buy |
2,416
+182
| +8% | +$102K | 0.03% | 207 |
|
|
2020
Q2 | $1.39M | Buy |
2,234
+435
| +24% | +$271K | 0.03% | 200 |
|
|
2020
Q1 | $878K | Sell |
1,799
-51
| -3% | -$24.9K | 0.02% | 223 |
|
|
2019
Q4 | $695K | Hold |
1,850
| – | – | 0.01% | 255 |
|
|
2019
Q3 | $513K | Sell |
1,850
-58
| -3% | -$16.1K | 0.01% | 258 |
|
|
2019
Q2 | $597K | Sell |
1,908
-6
| -0.3% | -$1.88K | 0.01% | 266 |
|
|
2019
Q1 | $786K | Sell |
1,914
-100
| -5% | -$41.1K | 0.02% | 256 |
|
|
2018
Q4 | $752K | Sell |
2,014
-6
| -0.3% | -$2.24K | 0.02% | 249 |
|
|
2018
Q3 | $816K | Hold |
2,020
| – | – | 0.02% | 269 |
|
|
2018
Q2 | $697K | Sell |
2,020
-80
| -4% | -$27.6K | 0.02% | 277 |
|
|
2018
Q1 | $723K | Sell |
2,100
-17,760
| -89% | -$6.11M | 0.02% | 281 |
|
|
2017
Q4 | $7.47M | Buy |
19,860
+42
| +0.2% | +$15.8K | 0.23% | 134 |
|
|
2017
Q3 | $8.86M | Buy |
19,818
+98
| +0.5% | +$43.8K | 0.28% | 119 |
|
|
2017
Q2 | $9.69M | Buy |
+19,720
| New | +$9.69M | 0.32% | 105 |
|